Enovis Corp (ENOV) Price to Earnings Ratio

Corporate emblem and logo of Enovis Corp (ENOV)

The increasing volume of procedures and an aging population are expanding the client base of Enovis Corporation (ENOV). The current P/E valuation based on GURU.Markets chart data, where the metric stands at -3.10, confirms the investment attractiveness. Stable revenue is driven by the conservatism of physicians when selecting implants, while the high cost of system services is supported by surgeons' lock-in to the company's specific technological solutions.

Enovis Inc. (ENOV) Price to Earnings Ratio: for the period 04/28/2023 - 11/17/2026
Original product of enovis.com

The P/E ratio determines the payback period of invested funds through the ratio of market value to net income, reflecting the current cost of one dollar of earnings. For Enovis Corporation (ENOV), this calculation confirms the scaling efficiency of orthopedic implant patents; therefore, a P/E business valuation analysis allows for the determination of a fair entry threshold and protects capital from overpaying for future growth.

Analysis of competing companies

Price to Earnings Ratio BSX|Price to Earnings Ratio EW (Edwards Lifesciences Corporation)|Business Payback Period ResMed Inc.|P/E Multiple PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Market Cap to Net Income|CooperSurgical - P/E Multiple|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Group (TMDX)|ATEC (Alphatec) - P/E Multiple|Price to Earnings Multiple AORT (Artivion)|Price to Earnings Ratio IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Company Value to Net Income|Price to Earnings Ratio iLet Bionic Pancreas BBNX|IRMD - Price to Earnings Ratio|Embecta Corp - P/E Multiple|Market Cap to Earnings Tandem Diabetes Care|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix Corp) - P/E Multiple|Price to Earnings Ratio Bioventus Corp (BVS)|P/E Multiple KIDS|Price to Earnings Ratio Treace Medical Concepts TMCI|P/E Multiple SRTA (blade.com)|P/E Multiple Carlsmed, Inc. CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis, Inc.) - Price to Earnings Ratio|Neuronetics, Inc. - Company Value to Net Income|SGHT (Sight Sciences Inc) - P/E Multiple|Market Cap to Earnings Orchestra BioMed Inc. OBIO|Price to Earnings Ratio Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Market Cap to Net Income Ratio|Jin Medical International Ltd. - Price to Earnings Ratio|P/E Multiple Vivani VANI|Xtant Medical Holdings, Inc. - P/E Multiple|Business Payback Period NeuroOne NMTC|Modular Medical, Inc. (MODD) - Price to Earnings Ratio|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio envoymedical.com|Price to Earnings Ratio Vivos Therapeutics (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical, Inc. TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|Business Payback Period invobioscience.com IVF|BBLG: P/E Multiple|Axonics Modulation Technologies (AXNX) - P/E Multiple|BIOL (Biolase Inc.) - P/E Multiple|Market Cap to Earnings dynatronics.com DYNT|P/E Multiple FNA|Price to Earnings Ratio INVO (INVO Bioscience Inc.)